| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
107.97(B) |
| Last
Volume: |
3,217,222 |
Avg
Vol: |
8,418,111 |
| 52
Week Range: |
$48.64 - $75.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
312,036 |
508,687 |
1,007,678 |
2,119,191 |
| Total Sell Value |
$23,117,519 |
$34,902,586 |
$61,221,104 |
$110,722,184 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
27 |
44 |
79 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
741 |
31,701 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$36,678 |
D/D |
(862) |
138,828 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,816 |
139,690 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$69,952 |
D/D |
(1,644) |
270,789 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
272,433 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$307,764 |
D/D |
(7,233) |
2,113,559 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,307 |
2,120,792 |
|
- |
|
| Sorenson John Bradley |
SVP, Global Supply Chain |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$15,446 |
D/D |
(363) |
35,443 |
|
- |
|
| Sorenson John Bradley |
SVP, Global Supply Chain |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,186 |
35,806 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$26,211 |
D/D |
(616) |
175,071 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,779 |
175,687 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$8,936 |
D/D |
(210) |
30,299 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
637 |
30,509 |
|
- |
|
| Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$13,914 |
D/D |
(327) |
24,375 |
|
- |
|
| Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,112 |
24,702 |
|
- |
|
| Mackey Edward F |
EVP, Operations |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$438,691 |
D/D |
(10,310) |
50,067 |
|
- |
|
| Mackey Edward F |
EVP, Operations |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,942 |
60,377 |
|
- |
|
| Meredith Ian T |
EVP Global Chief Med Officer |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$12,978 |
D/D |
(305) |
33,236 |
|
- |
|
| Meredith Ian T |
EVP Global Chief Med Officer |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,037 |
33,541 |
|
- |
|
| Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$47,869 |
D/D |
(1,125) |
91,610 |
|
- |
|
| Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,001 |
92,735 |
|
- |
|
| Olson Scott |
SVP & Pres, CRM, Diagnostics |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$21,701 |
D/D |
(510) |
14,074 |
|
- |
|
| Olson Scott |
SVP & Pres, CRM, Diagnostics |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,037 |
14,584 |
|
- |
|
| Pierce David A |
EVP Pres MedSurg |
• • – |
2022-02-18 |
4 |
AS |
$42.88 |
$100,940 |
D/D |
(2,354) |
1,884 |
|
-12% |
|
| Pierce David A |
EVP Pres MedSurg |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$33,359 |
D/D |
(784) |
4,238 |
|
- |
|
2518 Records found
|
|
Page 20 of 101 |
|
|
0.07 (0.09%) 
